| 1 |
28288631 | Effects of simvastatin on serum adiponectin: a meta-analysis of randomized controlled trials. | 2017 Mar 13 |
5 |
| 2 |
26884289 | Age may determine the effect of hypolipidemic agents on plasma adipokine levels in patients with elevated low-density lipoprotein cholesterol levels. | 2016 |
2 |
| 3 |
25931040 | Comparison of the effects of short-term hypolipidaemic treatment on plasma adipokine levels in men and women with isolated hypercholesterolaemia. | 2015 |
1 |
| 4 |
24354929 | The effect of simvastatin-ezetimibe combination therapy on adipose tissue hormones and systemic inflammation in patients with isolated hypercholesterolemia. | 2014 Apr |
1 |
| 5 |
25149995 | The effect of short-term simvastatin treatment on plasma adipokine levels in patients with isolated hypercholesterolemia: A preliminary report. | 2014 Oct |
1 |
| 6 |
25185849 | The effect of short-term combined treatment with simvastatin and ezetimibe on circulating adipokine levels in patients with isolated hypercholesterolemia. | 2014 |
1 |
| 7 |
25389496 | Effects of simvastatin treatment on serum adiponectin concentrations in patients with dislipidemia. | 2014 Aug |
2 |
| 8 |
22658637 | TNF-α modulates statin effects on secretion and expression of MCP-1, PAI-1 and adiponectin in 3T3-L1 differentiated adipocytes. | 2012 Oct |
1 |
| 9 |
18977478 | Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients. | 2009 Jun |
2 |
| 10 |
19889690 | Effect of simvastatin vs. rosuvastatin on adiponectin and haemoglobin A1c levels in patients with non-ischaemic chronic heart failure. | 2009 Dec |
1 |
| 11 |
18184901 | Simvastatin improves flow-mediated dilation but reduces adiponectin levels and insulin sensitivity in hypercholesterolemic patients. | 2008 Apr |
5 |
| 12 |
17273659 | Are the beneficial cardiovascular effects of simvastatin and metformin also associated with a hormone-dependent mechanism improving insulin sensitivity? | 2007 Feb |
1 |
| 13 |
17952841 | Visfatin: a putative biomarker for metabolic syndrome is not influenced by pioglitazone or simvastatin treatment in nondiabetic patients at cardiovascular risk -- results from the PIOSTAT study. | 2007 Oct |
2 |
| 14 |
15569835 | Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients. | 2004 Dec 14 |
1 |